chr6-15522822-C-CTT
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS1_Supporting
The NM_032122.5(DTNBP1):c.*151_*152dupAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000859 in 1,375,388 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00057 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00090 ( 1 hom. )
Consequence
DTNBP1
NM_032122.5 3_prime_UTR
NM_032122.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.73
Genes affected
DTNBP1 (HGNC:17328): (dystrobrevin binding protein 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. A similar protein in mouse is a component of a protein complex termed biogenesis of lysosome-related organelles complex 1 (BLOC-1), and binds to alpha- and beta-dystrobrevins, which are components of the dystrophin-associated protein complex (DPC). Mutations in this gene are associated with Hermansky-Pudlak syndrome type 7. This gene may also be associated with schizophrenia. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -1 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.000895 (1095/1223002) while in subpopulation NFE AF = 0.00112 (1031/919442). AF 95% confidence interval is 0.00106. There are 1 homozygotes in GnomAdExome4. There are 549 alleles in the male GnomAdExome4 subpopulation. Median coverage is 16. This position FAILED quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DTNBP1 | NM_032122.5 | c.*151_*152dupAA | 3_prime_UTR_variant | Exon 10 of 10 | ENST00000344537.10 | NP_115498.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000571 AC: 87AN: 152268Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
87
AN:
152268
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000895 AC: 1095AN: 1223002Hom.: 1 Cov.: 16 AF XY: 0.000891 AC XY: 549AN XY: 616064 show subpopulations
GnomAD4 exome
AF:
AC:
1095
AN:
1223002
Hom.:
Cov.:
16
AF XY:
AC XY:
549
AN XY:
616064
Gnomad4 AFR exome
AF:
AC:
6
AN:
28546
Gnomad4 AMR exome
AF:
AC:
21
AN:
41108
Gnomad4 ASJ exome
AF:
AC:
1
AN:
22886
Gnomad4 EAS exome
AF:
AC:
0
AN:
38216
Gnomad4 SAS exome
AF:
AC:
0
AN:
75876
Gnomad4 FIN exome
AF:
AC:
6
AN:
40874
Gnomad4 NFE exome
AF:
AC:
1031
AN:
919442
Gnomad4 Remaining exome
AF:
AC:
30
AN:
52408
Heterozygous variant carriers
0
49
98
148
197
246
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000571 AC: 87AN: 152386Hom.: 0 Cov.: 33 AF XY: 0.000309 AC XY: 23AN XY: 74518 show subpopulations
GnomAD4 genome
AF:
AC:
87
AN:
152386
Hom.:
Cov.:
33
AF XY:
AC XY:
23
AN XY:
74518
Gnomad4 AFR
AF:
AC:
0.00012021
AN:
0.00012021
Gnomad4 AMR
AF:
AC:
0.00111024
AN:
0.00111024
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.00095532
AN:
0.00095532
Gnomad4 OTH
AF:
AC:
0
AN:
0
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hermansky-Pudlak syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=100/0
polymorphism
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at